RxDoctor Payments Data

Colin Riley

Psychiatric/Mental Health · Layton, UTNPI 1497324370

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,353 and has fallen 81.0% since, to $257 in 2025.

$3,272in general payments, 2019–2025

Across 189 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$731
  • Teva Pharmaceuticals USA, Inc.$402
  • AbbVie$288
  • Neurocrine Biosciences, Inc.$271
  • Johnson & Johnson$269
  • Ironshore Pharmaceuticals Inc.$221
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,272 in reported general payments places this provider in the 85th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah

Other psychiatric/mental health in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →